OSR HEALTH, INC. Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect
OSR HEALTH, INC. (OSRH) reported Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect of -$84.03 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Cash Flow › Change in Cash
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect · last filed 2026-08-14
- OSR HEALTH, INC. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for the quarter ending 2026-03-31 was -$48.18K, a 103.79% decline year-over-year.
- OSR HEALTH, INC. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for the quarter ending 2025-03-31 was $1.27M.
- OSR HEALTH, INC. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for the quarter ending 2024-03-31 was -$5.56K, a 102.48% decline year-over-year.
- OSR HEALTH, INC. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for the quarter ending 2023-03-31 was $224.30K, a 1827.81% increase year-over-year.
- OSR HEALTH, INC. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for fiscal 2025 was $1.40M.
- OSR HEALTH, INC. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for fiscal 2024 was -$161.53K.
- OSR HEALTH, INC. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for fiscal 2023 was -$109.08K, a 191.10% decline from fiscal 2022.
- OSR HEALTH, INC. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for fiscal 2022 was $119.74K.
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect 3 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect 3 month as first filed | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect 6 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect 6 month as first filed | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect 9 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect 9 month as first filed | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect 12 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$84.03K 10-Q · filed 2026-08-14 | |||||||
| 2026-03-31 | -$48.18K 10-Q · filed 2026-05-13 | |||||||
| 2025-12-31 | $1.40M 10-K · filed 2026-03-31 | |||||||
| 2025-09-30 | $1.83M 10-Q · filed 2025-11-12 | |||||||
| 2025-06-30 | $1.15M 10-Q · filed 2026-08-14 | |||||||
| 2025-03-31 | $1.27M 10-Q · filed 2026-05-13 | $1.27M 10-Q · filed 2025-05-20 | ||||||
| 2024-12-31 | -$161.53K 10-K · filed 2026-03-31 | $50.72K 10-K · filed 2025-04-22 | ||||||
| 2024-09-30 | -$114.20K 10-Q · filed 2025-11-12 | -$3.18K 10-Q · filed 2024-11-14 | ||||||
| 2024-06-30 | -$10.95K 10-Q · filed 2025-08-14 | $103.70K 10-Q · filed 2024-08-19 | ||||||
| 2024-03-31 | -$5.56K 10-Q · filed 2025-05-20 | -$11.78K 10-Q · filed 2024-05-15 | ||||||
| 2023-12-31 | -$109.08K 10-K · filed 2025-04-22 | |||||||
| 2023-09-30 | -$66.55K 10-Q · filed 2024-11-14 | |||||||
| 2023-06-30 | -$123.32K 10-Q · filed 2024-08-19 | |||||||
| 2023-03-31 | $224.30K 10-Q · filed 2024-05-15 | |||||||
| 2022-12-31 | $119.74K 10-K · filed 2024-04-17 | |||||||
| 2022-09-30 | $64.08K 10-Q · filed 2023-11-07 | |||||||
| 2022-06-30 | $69.42K 10-Q · filed 2023-08-14 | |||||||
| 2022-03-31 | $11.63K 10-Q · filed 2023-05-22 | |||||||
| 2021-12-31 | -$57.90K 10-K · filed 2023-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B | |
| AETHLON MEDICAL INC (AEMD) | United States | $0.005B | |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B | |
| NEXGEL, INC. (NXGL) | United States | $0.002B | |
| INVO Fertility, Inc. (IVF) | United States | $0.002B | -0.71 |
| Sonoma Pharmaceuticals, Inc. (SNOA) | United States | $0.006B | -2.59 |